3SBio leads slide in HK pharmaceutical firms amid China's vaccine scandal
24/07/2018 08:58
** Shares of pharmaceutical products producer 3SBio Inc
1530.HK lead a slide in pharmaceutical firms in late trade in
Hong Kong, falling 5.9 percent and heading for its biggest
single day of decline in percentage terms since July 4, 2017
** The stock falls to HK$16.96, lowest since July 11, 2018
** A vaccine scandal in China, which has prompted angry
reactions from citizens fed up with safety scares, is sending
ripples across the local drug market. urn:newsml:reuters.com:*:nL4N1UJ1ET
** China Medical System 0867.HK falls 3.2 percent, CSPC
Pharmaceutical 1093.HK slides 3.03 percent, WuXi Bio 2269.HK
eases 2.9 percent and Sino Biopharm 1177.HK is down 2.8
percent
** Hong Kong benchmark index .HSI rises 1.3 percent
(RM: donny.kwok.thomsonreuters.com@reuters.net)